Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Endpoint Outcomes was a private healthcare research and consulting company focused on patient-centered outcomes research, clinical outcomes assessments, and health economics and outcomes research for biopharma clients. The company specialized in developing and validating patient-centric endpoint strategies and evidence packages used in drug development, regulatory submissions, payer evaluation, and health technology assessment. Its work centered on patient-reported, clinician-reported, observer-reported, and performance outcome measures rather than developing therapeutic products of its own. In June 2022, Endpoint Outcomes was acquired by Lumanity, and in September 2022 the Endpoint brand was retired as the business adopted the Lumanity name. The company is therefore best understood as a former specialized HEOR/COA consulting firm whose capabilities were integrated into Lumanity's broader patient-centered outcomes and value demonstration offering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Endpoint Outcomes.